Tower Research Capital (TRC)’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $108K | Buy |
7,429
+4,088
| +122% | +$55.2K | ﹤0.01% | 2130 |
|
|
2026
Q1 | $46.3K | Buy |
+3,341
| New | +$46.5K | ﹤0.01% | 2803 |
|
|
2025
Q4 | – | Sell |
-860
| Closed | -$12K | – | 5506 |
|
|
2025
Q3 | $12K | Buy |
860
+651
| +311% | +$9.37K | ﹤0.01% | 3827 |
|
|
2025
Q2 | $3.14K | Buy |
+209
| New | +$2.98K | ﹤0.01% | 4544 |
|
|
2025
Q1 | – | Sell |
-3,032
| Closed | -$47.9K | – | 5680 |
|
|
2024
Q4 | $47.9K | Buy |
3,032
+937
| +45% | +$14.1K | ﹤0.01% | 2579 |
|
|
2024
Q3 | $33.3K | Buy |
+2,095
| New | +$33.7K | ﹤0.01% | 2946 |
|
|
2024
Q2 | – | Sell |
-1,090
| Closed | -$16K | – | 5955 |
|
|
2024
Q1 | $16K | Sell |
1,090
-1,200
| -52% | -$17.5K | ﹤0.01% | 3212 |
|
|
2023
Q4 | $31.9K | Sell |
2,290
-7,445
| -76% | -$99.5K | ﹤0.01% | 3392 |
|
|
2023
Q3 | $130K | Buy |
9,735
+9,460
| +3,440% | +$128K | ﹤0.01% | 1766 |
|
|
2023
Q2 | $3.47K | Sell |
275
-19,380
| -99% | -$226K | ﹤0.01% | 5072 |
|
|
2023
Q1 | $223K | Buy |
19,655
+17,745
| +929% | +$192K | 0.01% | 1308 |
|
|
2022
Q4 | $20K | Buy |
1,910
+145
| +8% | +$1.56K | ﹤0.01% | 3143 |
|
|
2022
Q3 | $18K | Sell |
1,765
-1,845
| -51% | -$19.6K | ﹤0.01% | 4021 |
|
|
2022
Q2 | $40K | Sell |
3,610
-5,920
| -62% | -$64.4K | ﹤0.01% | 3108 |
|
|
2022
Q1 | $106K | Buy |
9,530
+9,125
| +2,253% | +$103K | ﹤0.01% | 2156 |
|
|
2021
Q4 | $5K | Sell |
405
-445
| -52% | -$5.61K | ﹤0.01% | 5187 |
|
|
2021
Q3 | $11K | Sell |
850
-22,080
| -96% | -$294K | ﹤0.01% | 4249 |
|
|
2021
Q2 | $337K | Buy |
22,930
+9,470
| +70% | +$132K | 0.01% | 1499 |
|
|
2021
Q1 | $165K | Buy |
13,460
+1,640
| +14% | +$21.1K | ﹤0.01% | 2166 |
|
|
2020
Q4 | $169K | Sell |
11,820
-11,615
| -50% | -$156K | 0.01% | 1851 |
|
|
2020
Q3 | $326K | Buy |
+23,435
| New | +$279K | ﹤0.01% | 2108 |
|
|
2020
Q2 | – | Sell |
-36,700
| Closed | -$296K | – | 4947 |
|
|
2020
Q1 | $296K | Sell |
36,700
-1,925
| -5% | -$16K | 0.02% | 608 |
|
|
2019
Q4 | $313K | Buy |
38,625
+36,755
| +1,966% | +$290K | 0.03% | 430 |
|
|
2019
Q3 | $14K | Sell |
1,870
-34,180
| -95% | -$254K | ﹤0.01% | 2732 |
|
|
2019
Q2 | $270K | Buy |
+36,050
| New | +$283K | 0.02% | 728 |
|
|
2019
Q1 | – | Sell |
-7,845
| Closed | -$59K | – | 4191 |
|
|
2018
Q4 | $59K | Sell |
7,845
-5,440
| -41% | -$38.3K | ﹤0.01% | 1196 |
|
|
2018
Q3 | $92K | Sell |
13,285
-95,570
| -88% | -$639K | 0.01% | 1402 |
|
|
2018
Q2 | $701K | Buy |
108,855
+108,140
| +15,124% | +$682K | 0.04% | 489 |
|
|
2018
Q1 | $5K | Buy |
+715
| New | +$5.01K | ﹤0.01% | 2721 |
|
|
2017
Q4 | – | Sell |
-12,275
| Closed | -$88K | – | 3920 |
|
|
2017
Q3 | $88K | Buy |
12,275
+10,380
| +548% | +$74.6K | 0.01% | 1481 |
|
|
2017
Q2 | $16K | Sell |
1,895
-4,470
| -70% | -$36.3K | ﹤0.01% | 1341 |
|
|
2017
Q1 | $51K | Buy |
6,365
+3,245
| +104% | +$28K | 0.01% | 725 |
|
|
2016
Q4 | $28K | Buy |
+3,120
| New | +$29K | ﹤0.01% | 1846 |
|
|
2016
Q3 | – | Sell |
-1,315
| Closed | -$13K | – | 4289 |
|
|
2016
Q2 | $13K | Sell |
1,315
-5,590
| -81% | -$51.2K | ﹤0.01% | 2599 |
|
|
2016
Q1 | $63K | Buy |
6,905
+6,875
| +22,917% | +$61.5K | 0.01% | 670 |
|
|
2015
Q4 | $0 | Buy |
+30
| New | +$329 | ﹤0.01% | 4954 |
|
|
2015
Q3 | – | Sell |
-3,375
| Closed | -$37K | – | 4627 |
|
|
2015
Q2 | $37K | Buy |
3,375
+2,875
| +575% | +$31.7K | ﹤0.01% | 1598 |
|
|
2015
Q1 | $6K | Sell |
500
-14,235
| -97% | -$151K | ﹤0.01% | 3160 |
|
|
2014
Q4 | $149K | Buy |
+14,735
| New | +$155K | 0.01% | 411 |
|
|
2014
Q3 | – | Sell |
-6,520
| Closed | -$56K | – | 4810 |
|
|
2014
Q2 | $56K | Buy |
+6,520
| New | +$54.8K | 0.01% | 1227 |
|
|
2014
Q1 | – | Sell |
-20,890
| Closed | -$182K | – | 4838 |
|
|
2013
Q4 | $171K | Buy |
20,890
+1,925
| +10% | +$15.2K | 0.03% | 590 |
|
|
2013
Q3 | $143K | Buy |
18,965
+14,220
| +300% | +$103K | 0.02% | 994 |
|
|
2013
Q2 | $36K | Buy |
+4,745
| New | +$34.6K | ﹤0.01% | 1190 |
|
Other funds holding RDY
AIM
Tower Research Capital (TRC)'s RDY Position: Q2 2026 in Review
Tower Research Capital (TRC) increased its Dr. Reddy's Laboratories (RDY) stake by 122% in Q2 2026, buying an estimated $55.2K and bringing the position to 7,429 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #2130.
Tower Research Capital (TRC) first reported a position in RDY in Q2 2013 and has held it in 43 quarters since. The position peaked at $701K in Q2 2018. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Tower Research Capital (TRC) held 7,429 shares of Dr. Reddy's Laboratories worth $108K as of Q2 2026.
- Tower Research Capital (TRC) bought 4,088 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $55.2K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2130 holding.
- Tower Research Capital (TRC) first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 43 quarters since.
- Tower Research Capital (TRC)'s Dr. Reddy's Laboratories position peaked at $701K in Q2 2018.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.